HealthFinSMEsabout 2 hours ago
Vitroscope Raises $7M for Biotech Platform
1 min read
Vitroscope, a Trondheim-based biotech firm, raised $7M in funding to support the commercial rollout of vitro.alive and validation of vitro.scale. The round included a $5M seed investment from Cerberus Ventures and YZR Capital, plus $2M non-dilutive funding from the Research Council of Norway, bringing the total to $8.8M.
Level
Hype check
Tap to vote and see what everyone thinks.
